These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14685080)

  • 1. Are proton pump inhibitors indicated for the treatment of gastroesophageal reflux in infants and children?
    Rudolph CD
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S60-4. PubMed ID: 14685080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophagitis in children: an update on current pharmacotherapy.
    Shashidhar H; Tolia V
    Expert Opin Pharmacother; 2013 Dec; 14(18):2475-87. PubMed ID: 24138403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the latest chemical therapies for reflux esophagitis in children.
    Bardou M; Fortinsky KJ; Chapelle N; Luu M; Barkun A
    Expert Opin Pharmacother; 2019 Feb; 20(2):231-239. PubMed ID: 30496693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of pediatric gastroesophageal reflux disease and proton pump inhibitor therapy.
    Colletti RB; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S7-S11. PubMed ID: 14685071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.
    Romano C; Chiaro A; Comito D; Loddo I; Ferrau V
    Curr Clin Pharmacol; 2011 Feb; 6(1):41-7. PubMed ID: 21235462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.
    Illueca M; Wernersson B; Henderson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of medication options for treating pediatric esophagitis.
    Bardou M; Fortinsky KJ
    Expert Opin Drug Saf; 2015 Jul; 14(7):1087-96. PubMed ID: 25913014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
    Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S; Bueno de Mesquita M; Mimouni FB
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of gastroesophageal reflux in infants and children.
    Ault DL; Schmidt D
    Nurse Pract; 1998 Jun; 23(6):78, 81-2, 88-9 passim. PubMed ID: 9656260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients.
    Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M
    J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole maintenance therapy for gastroesophageal reflux disease after failure of fundoplication.
    Pashankar D; Blair GK; Israel DM
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):145-9. PubMed ID: 11321383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid secretion from birth to adulthood.
    Boyle JT
    J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S12-6. PubMed ID: 14685072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease?
    Chung EY; Yardley J
    Hosp Pediatr; 2013 Jan; 3(1):16-23. PubMed ID: 24319831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastroesophageal reflux in infants: myths and realities].
    Baudon JJ
    Arch Pediatr; 2009 May; 16(5):468-73. PubMed ID: 19303264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26121347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.